Form 4: UiPath GC Sells Shares Under 10b5-1 Plan

UiPath's General Counsel and Chief Legal Officer, Brad Brubaker, sold 27,580 shares of Class A Common Stock for an average price of $16.6761 under a pre-arranged 10b5-1 plan.

Summary

• Brad Brubaker, UiPath's General Counsel and Chief Legal Officer, reported a sale of Class A Common Stock.
• The transaction involved the disposition of 27,580 shares.
• The shares were sold on October 15, 2025, at an average price of $16.6761 per share.
• The price range for the transactions was between $16.2100 and $17.2000.
• The sale was conducted in compliance with a qualified selling plan adopted by Mr. Brubaker pursuant to Rule 10b5-1.
• Following this transaction, Mr. Brubaker beneficially owns 662,939 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine insider sale conducted under a pre-arranged 10b5-1 plan, which is generally considered a neutral event and not indicative of new material information about the company's performance or outlook.

Future Outlook

The filing does not contain any forward-looking statements or guidance, as it is a report of a past insider transaction.

Industry Context

This insider transaction is a routine event for a corporate executive and does not inherently reflect broader industry trends or competitive dynamics within the automation software sector. Sales under Rule 10b5-1 plans are pre-scheduled and typically for personal financial planning.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, but given it's under a 10b5-1 plan, it's unlikely to be interpreted as a lack of confidence in the company's future. The impact is minimal.

Key Dates

Recommendation

The reported transaction is a routine insider sale by a General Counsel under a Rule 10b5-1 plan. Such pre-scheduled sales are typically for personal financial management and do not usually signal a change in the company's fundamentals or future prospects. Therefore, this specific filing does not provide sufficient new information to warrant a change from a 'hold' recommendation for the stock.

Keywords

UiPath, PATH, Form 4, Insider Transaction, Stock Sale, 10b5-1 Plan, Brad Brubaker, General Counsel, Equity Disposition